Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) ("Calidi” or the "Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced the closing of its ...

Stock Connect reshuffle reflects biotech sector's growing role on international stage, though overseas funds remain cautious Mainland Chinese investors can now buy shares in more than a dozen newly ...

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more ...

Some biotechs that had seen regulatory setbacks under Center for Biologics Evaluation and Research director Vinay Prasad experienced stock bumps Monday morning. Under Prasad’s leadership, the rare ...

MGP Global Partner, an investment management company, released its fourth quarter 2025 investor letter for the "iMGP Small ...

What would allow Viking Therapeutics to match Wall Street's average price target, or at least get close to it? The biotech ...

Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine chief, Dr. Vinay Prasad. Prasad, the head of the FDA’s division of vaccines and ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down. A controversial political appointee at the Food and Drug Administration plans to step down for a second ...